Evidence map›Paper›PMID 39059040›Full record

ArticlePsychiatry research2024

Evaluating generative AI responses to real-world drug-related questions.

Salvatore Giorgi, Kelsey Isman, Tingting Liu, Zachary Fried, João Sedoc, Brenda Curtis

Abstract read
In one paragraph

Article in Psychiatry research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Salvatore GiorgiNational Institute on Drug Abuse, Baltimore, MD, USA; University of Pennsylvania, Philadelphia, PA, USA.
Kelsey IsmanNational Institute on Drug Abuse, Baltimore, MD, USA.
Tingting LiuNational Institute on Drug Abuse, Baltimore, MD, USA.
Zachary FriedNational Institute on Drug Abuse, Baltimore, MD, USA.
João SedocNew York University, New York, NY, USA.
Brenda CurtisNational Institute on Drug Abuse, Baltimore, MD, USA. Electronic address: brenda.curtis@nih.gov.

Funding

Digital Markers in Relapse and RecoveryZIADA000628 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI CURTIS, BRENDA · 2019 to 2025
$10.0M
Digital Phenotyping & Deep Learning: Substance Use Impact on PrEP Adherence among Black Sexual and Gender MinoritiesZIADA000646 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI CURTIS, BRENDA · 2023 to 2025
$4.0M
Intramural NIH HHS ZIA DA000628
6 · The paper itself

Abstract

Generative Artificial Intelligence (AI) systems such as OpenAI's ChatGPT, capable of an unprecedented ability to generate human-like text and converse in real time, hold potential for large-scale deployment in clinical settings such as substance use treatment. Treatment for substance use disorders (SUDs) is particularly high stakes, requiring evidence-based clinical treatment, mental health expertise, and peer support. Thus, promises of AI systems addressing deficient healthcare resources and structural bias are relevant within this domain, especially in an anonymous setting. This study explores the effectiveness of generative AI in answering real-world substance use and recovery questions. We collect questions from online recovery forums, use ChatGPT and Meta's LLaMA-2 for responses, and have SUD clinicians rate these AI responses. While clinicians rated the AI-generated responses as high quality, we discovered instances of dangerous disinformation, including disregard for suicidal ideation, incorrect emergency helplines, and endorsement of home detox. Moreover, the AI systems produced inconsistent advice depending on question phrasing. These findings indicate a risky mix of seemingly high-quality, accurate responses upon initial inspection that contain inaccurate and potentially deadly medical advice. Consequently, while generative AI shows promise, its real-world application in sensitive healthcare domains necessitates further safeguards and clinical validation.

Indexed as

Artificial IntelligenceSubstance-Related DisordersHumansSuicidal IdeationAlcoholGenerative AILarge language modelsMarijuanaOpioidsSubstance use

Identifiers

PMID39059040
PMCPMC11705880

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.